Maria C. Cursano

Meldola, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group.

Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group.

Journal: Cancer metastasis reviews

Published: April 02, 2026

Validation of a large language model as a decision tool for drug interaction in prostate cancer: A comparative study against UpToDate. Meet-URO 5/25 - GENIE study.

Validation of a large language model as a decision tool for drug interaction in prostate cancer: A comparative study against UpToDate. Meet-URO 5/25 - GENIE study.

Journal: Journal of geriatric oncology

Published: November 16, 2025

Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?

Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of '-mabs'?

Journal: The Journal of pathology

Published: September 03, 2025

Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review.

Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review.

Journal: Clinical genitourinary cancer

Published: April 05, 2025

Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA.

Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA.

Journal: Scientific reports

Published: December 05, 2024

Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 26, 2024

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies.

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies.

Journal: ESMO open

Published: March 19, 2024

Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study.

Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study.

Journal: iScience

Published: February 06, 2024

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study.

Journal: European urology open science

Published: January 25, 2024

Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer.

Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer.

Journal: International journal of molecular sciences

Published: July 07, 2023

Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.

Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.

Journal: The oncologist

Published: June 19, 2023

Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.

Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients.

Journal: Frontiers in oncology

Published: May 11, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026